Question 26 The following pharmacokinetic data for N-acetylprocainamide (NAPA) were obtained in a Phase 1 study in volun

Business, Finance, Economics, Accounting, Operations Management, Computer Science, Electrical Engineering, Mechanical Engineering, Civil Engineering, Chemical Engineering, Algebra, Precalculus, Statistics and Probabilty, Advanced Math, Physics, Chemistry, Biology, Nursing, Psychology, Certifications, Tests, Prep, and more.
Post Reply
answerhappygod
Site Admin
Posts: 899603
Joined: Mon Aug 02, 2021 8:13 am

Question 26 The following pharmacokinetic data for N-acetylprocainamide (NAPA) were obtained in a Phase 1 study in volun

Post by answerhappygod »

Question 26 The Following Pharmacokinetic Data For N Acetylprocainamide Napa Were Obtained In A Phase 1 Study In Volun 1
Question 26 The Following Pharmacokinetic Data For N Acetylprocainamide Napa Were Obtained In A Phase 1 Study In Volun 1 (40.29 KiB) Viewed 64 times
Question 26 The following pharmacokinetic data for N-acetylprocainamide (NAPA) were obtained in a Phase 1 study in volunteers with normal kidney function: • Elimination half-life: 6.2 h. • Elimination clearance: 233 mL/min. • % Renal excretion: 75.8% Use these results to predict the elimination half-life of NAPA in functionally anephric patients, assuming that nonrenal clearance is unchanged in these individuals. 25.6 h 12.4 h 42.7 h 1 pts 35.6 h 8.2 h
Join a community of subject matter experts. Register for FREE to view solutions, replies, and use search function. Request answer by replying!
Top
Post Reply

Return to “Archived Questions & Answers”